𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety of methacholine challenges in a multicenter pediatric asthma study

✍ Scribed by Covar, Ronina A.; Colvin, Ryan; Shapiro, Gail; Strunk, Robert

Book ID
119277529
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
89 KB
Volume
117
Category
Article
ISSN
1097-6825

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Later development of asthma in patients
Later development of asthma in patients with a negative methacholine inhalation challenge examined for suspected asthma
✍ Hannu Puolijoki; Olli Impivaara; Kari Liippo; Eero Tala πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 370 KB

A negative methacholine inhalation challenge (MIC) in a patient with suspected bronchial asthma is generally considered to make this diagnosis unlikely. Nevertheless, the patient may later develop asthma. To estimate the proportion that eventually becomes asthmatic, a 10 year follow-up study was car

A cumulative dose, safety and tolerabili
A cumulative dose, safety and tolerability study of arformoterol in pediatric subjects with stable asthma
✍ J. Hinkle; J. Hinson; E. Kerwin; E. Goodwin; K. Sciarappa; L. Curry; J.P. Hanrah πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 170 KB

## Abstract ## Purpose Short‐acting Ξ²~2~‐agonists (SABAs) are recommended for treating acute pediatric asthma. The long‐acting Ξ²~2~‐agonist (LABA) arformoterol is approved for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Arformoterol acts rapidly, is delivered via neb